NCT06271525

Brief Summary

this study will be conducted to investigate the effect of cupping therapy on the nitric oxide level in patients with cervical spondylosis

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

February 20, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2024

Completed
Last Updated

February 21, 2024

Status Verified

February 1, 2024

Enrollment Period

3 months

First QC Date

February 14, 2024

Last Update Submit

February 14, 2024

Conditions

Keywords

cupping therapyCervical Spondylosis

Outcome Measures

Primary Outcomes (1)

  • the nitric oxide level

    Spectrophotometer device will be used to measure the level of nitric oxide

    up to three months

Secondary Outcomes (2)

  • cervical range of motion

    up to three months

  • pain intensity

    up to three months

Study Arms (1)

cupping therapy

EXPERIMENTAL

patients with cervical spondylosis will receive cupping therapy one time per month for three months

Other: cupping therapy

Interventions

All the patients will be asked to be in a sitting position with both feet flat on the floor the cupping group will receive the cupping bloodletting at three acupuncture points (SI15, GB21, LI15) the medium size glass with a diameter of 4cm and a volume of 260ml. Each wet cupping treatment procedure will last about 20 min and will be conducted in five steps. 1. -Primary sucking 2. -Scarification 3- Bloodletting 4-Removal 5 -Dressing

cupping therapy

Eligibility Criteria

Age24 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with (cervical spondylosis) from both sexes.
  • Age range (24-60) in chronic stages.
  • BMI from20-25 kg/m2.

You may not qualify if:

  • Renal and hepatic patients.
  • Anemia, hepatic disease, and dermatological diseases.
  • Morbid obese patients if their BMI exceeds the 25 kg/m2 will be also excluded.
  • the patients are taking any medications known to affect the pain level
  • The patients have a systemic illness, dermatological problems, skin allergy, local ischemic problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Spondylosis

Interventions

Cupping Therapy

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: cupping therapy
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
principle investigator shady abdelsattar refaat

Study Record Dates

First Submitted

February 14, 2024

First Posted

February 21, 2024

Study Start

February 20, 2024

Primary Completion

May 20, 2024

Study Completion

May 20, 2024

Last Updated

February 21, 2024

Record last verified: 2024-02